The Second People's Hospital of Neijiang

Neijiang, Sichuan 641100

1 studies enrolling now · 3 studies all time

What they study most

Breast Neoplasms, Neoplasm Metastasis, Non-small Cell Lung Cancer, Triple Negative Breast Cancer

Studies at this site

• A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% — Recruiting now
• A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer — Running, not enrolling
• A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer — Stopped early